North America Oral Solid Dosage Contract Manufacturing Market Size & Outlook
Related Markets
North America oral solid dosage contract manufacturing market highlights
- The North America oral solid dosage contract manufacturing market generated a revenue of USD 12,776.0 million in 2024.
- The market is expected to grow at a CAGR of 6% from 2025 to 2030.
- In terms of segment, tablets was the largest revenue generating product in 2024.
- Capsules is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, U.S. is expected to register the highest CAGR from 2025 to 2030.
North America data book summary
| Market revenue in 2024 | USD 12,776.0 million |
| Market revenue in 2030 | USD 18,120.0 million |
| Growth rate | 6% (CAGR from 2025 to 2030) |
| Largest segment | Tablets |
| Fastest growing segment | Capsules |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Tablets, Capsules, Powders, Granules |
| Key market players worldwide | Catalent Inc, Lonza Group Ltd, Boehringer Ingelheim, Jubilant Pharmova, Novacyt SA, Thermo Fisher Scientific Inc, Recipharm, CordenPharma, Siegfried Holding AG, Piramal Pharma Solutions, AbbVie Inc |
Other key industry trends
- In terms of revenue, North America region accounted for 33.1% of the global oral solid dosage contract manufacturing market in 2024.
- Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 19,479.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Oral Solid Dosage Contract Manufacturing Market Scope
Oral Solid Dosage Contract Manufacturing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Novacyt SA | View profile | 222 | 13, Avenue Morane Saulnier, Velizy-Villacoublay, France, 78140 | https://www.novacyt.com |
| Jubilant Pharmova | View profile | 10001+ | Noida, Uttar Pradesh, India, Asia | https://www.jubilantpharmova.com |
| CordenPharma | View profile | 5001-10000 | Plankstadt, Baden-Wurttemberg, Germany, Europe | http://cordenpharma.com |
| Piramal Pharma Solutions | View profile | 1001-5000 | Riverview, Michigan, United States, North America | http://www.piramalpharmasolutions.com/ |
| Recipharm | View profile | 1001-5000 | Jordbro, Stockholms Lan, Sweden, Europe | http://www.recipharm.com |
| Siegfried Holding AG | View profile | 4180 | Untere Bruehlstrasse 4, Zofingen, Switzerland, CH-4800 | https://www.siegfried.ch |
| Catalent Inc | View profile | 17219 | 14 Schoolhouse Road, Somerset, NJ, United States, 08873 | https://www.catalent.com |
| Boehringer Ingelheim | View profile | 10001+ | Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe | https://www.boehringer-ingelheim.com/ |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Lonza Group Ltd | View profile | 18000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | https://www.lonza.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
North America oral solid dosage contract manufacturing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to oral solid dosage contract manufacturing market will help companies and investors design strategic landscapes.
Tablets was the largest segment with a revenue share of 32.22% in 2024. Horizon Databook has segmented the North America oral solid dosage contract manufacturing market based on tablets, capsules, powders, granules covering the revenue growth of each sub-segment from 2018 to 2030.
North America accounts for 31.5% share in the global oral solid dosage contract manufacturing market owing to growing investments in R&D of new drugs by pharmaceutical companies, which boosts the demand for oral solid dosage contract manufacturing. The growth of pharmaceutical industry in the U.S. and Canada is a key factor contributing to market growth.
The expansion of the market in the region can be attributed to the presence of technologically advanced Contract Manufacturing Organizations (CMOs) & Contract Development and Manufacturing Organizations (CDMOs) and a surge in the allocation of grants.
Furthermore, increasing drug development activities, strategic measures like innovation & acquisitions, the presence of pharmaceutical companies, and a surge in the demand for oral solid dosage products in the region are among key factors propelling the market growth.
Reasons to subscribe to North America oral solid dosage contract manufacturing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America oral solid dosage contract manufacturing market databook
-
Our clientele includes a mix of oral solid dosage contract manufacturing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America oral solid dosage contract manufacturing market , including forecasts for subscribers. This continent databook contains high-level insights into North America oral solid dosage contract manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America oral solid dosage contract manufacturing market size, by country, 2018-2030 (US$M)
North America Oral Solid Dosage Contract Manufacturing Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
